Newormics resumes operations

Dear Colleagues, Customers, and Collaborators: At our Newormics location in Austin, TX, we have been allowed to re-open. We have resumed operations in our lab and in our manufacturing facility as of August 1st. This means we can now be contacted for purchasing our vivoCube system, accessory kits, and for obtaining more vivoChips for your Read more about Newormics resumes operations[…]

Newormics Announces Intent to Grant Utility Patent on the vivoChip® by the European Patent Office

Patent covers the vivoChip® invention that Newormics licensed for use in immobilization of C. elegans for high resolution imaging. AUSTIN, TX. August 5, 2020 – Newormics LLC, a developer of the first high-throughput, high-content screening platforms for use with in vivo small animal models, announced that the European Patent Office (EPO) intends to grant a patent covering the vivoChip® technology, Read more about Newormics Announces Intent to Grant Utility Patent on the vivoChip® by the European Patent Office[…]

Newormics awarded SBIR Phase II grant from the NIMH

Newormics is excited to announce it has been awarded a $2.25M Phase II SBIR grant from the National Institutes of Health/National Institute of Mental Health (NIMH) for the continued development of the company’s in vivo imaging and screening technologies. Newormics core focus is to facilitate the use of C. elegans as a model organism for Read more about Newormics awarded SBIR Phase II grant from the NIMH[…]